LEUKOTRIENES, LEUKOTRIENE RECEPTOR ANTAGONISTS AND LEUKOTRIENE SYNTHESIS INHIBITORS IN ASTHMA: AN UPDATE. PART II: CLINICAL STUDIES WITH LEUKOTRIENE RECEPTOR ANTAGONISTS AND LEUKOTRIENE SYNTHESIS INHIBITORS IN ASTHMA

This publication has 97 references indexed in Scilit:

• A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene–receptor antagonist
  Journal of Allergy and Clinical Immunology, 1998
• Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced Bronchoconstriction
  New England Journal of Medicine, 1998
• Pharmacological characterization of the cysteinyl-leukotriene antagonists CGP 45715A (iralukast) and CGP 57698 in human airwaysin vitro
  British Journal of Pharmacology, 1998
• Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005
  Thorax, 1997
• Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids
  Thorax, 1997
• Pharmacodynamics and pharmacokinetics of BAY x 7195 aerosol, a new and selective receptor antagonist of cysteinyl‐leukotrienes, in normal volunteers
  British Journal of Clinical Pharmacology, 1996
• Inhibition by a novel peptide leukotriene receptor antagonist ONO‐1078 of airway wall thickening and airway hyperresponsiveness to histamine induced by leukotriene C₄ or leukotriene D₄ in guinea‐pigs
  Clinical and Experimental Allergy, 1994
• Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.
  Thorax, 1994
• Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole bloodex vivo
  Inflammation Research, 1991
• Effect of the oral leukotriene D antagonist LY171883 on inhaled and intradermal challenge with antigen and leukotriene D in atopic subjects
  Journal of Allergy and Clinical Immunology, 1989